News Hub | News Direct

Synergist Technology Partners with Microsoft to Drive Ethical and Compliant AI Innovation

Synergist

Synergist Technology, a leader in AI governance and compliance, announces a strategic partnership with Microsoft, aimed at advancing the development and deployment of compliant AI solutions. By integrating Synergist’s expertise with Microsoft’s robust cloud infrastructure, the partnership seeks to address the growing market demands for ethical and secure AI systems. As the rapid adoption of AI continues to outpace regulatory frameworks, many organizations face significant challenges in deploying AI technologies with accountability. Together, the companies will provide comprehensive AI solutions that help businesses navigate the complex landscape of AI regulations while maximizing the potential of Microsoft’s AI offerings. The partnership is further strengthened by the involvement of key partners, including Pliant Consulting and Maureen Data Systems, which will assist in integrating and enhancing AI solutions for clients. This collaborative effort ensures that customers can navigate the complexities of AI governance with ease and assurance. “With over 700 pieces of proposed regulation at the state and federal level, our partnership with Microsoft represents a significant step forward in our mission to bring responsible AI to every organization,” said Elycia Morris, CEO of Synergist Technology. “By combining our governance and compliance expertise with Microsoft’s advanced technologies, we are creating a powerful synergy that will enable organizations to harness the transformative power of AI while maintaining trust and transparency.” “This partnership enables organizations to confidently leverage AI’s transformative power while adhering to the highest standards of regulatory adherence,” said Vishal Amin, General Manager of Security Solutions, Microsoft. “Microsoft and Synergist have a shared commitment to empower businesses to achieve more through innovation and trust.” Since the inception of the partnership, Synergist has made significant strides in its go-to-market strategy, leveraging Microsoft programs such as the ISV Success Program to expand the reach of its offerings. This strategic collaboration is set to evolve further, with plans to integrate Synergist’s AFFIRM platform into Microsoft’s Marketplace, making it more accessible to businesses worldwide. About Synergist Technology Synergist Technologies is a leader in AI governance and compliance, specializing in enabling ethical and compliant AI innovation through their AFFIRM platform. Their solutions help organizations navigate the complexities of AI regulations, ensuring responsible and effective AI deployment.For more information, visit https://synergist.technology/. Contact Details Julia Worthington synergist@kitehillpr.com

August 29, 2024 09:00 AM Eastern Daylight Time

Benchmark International Releases Global Semiconductor Machinery Manufacturing Industry Report, Spotlighting Market Growth and Key Trends

Benchmark International

Benchmark International, a leader in the mergers and acquisition (M&A) industry, has published its latest Global Semiconductor Machinery Manufacturing Industry Report. This comprehensive analysis provides critical insights into the rapidly evolving semiconductor machinery sector, highlighting growth opportunities, industry challenges, and emerging trends that are reshaping the landscape. As the global demand for semiconductors continues to soar, driven by advancements in artificial intelligence, 5G, and consumer electronics, the semiconductor machinery manufacturing industry is experiencing significant growth. Benchmark International’s report delves into the key factors influencing this sector, from technological innovations to geopolitical developments that are shaping supply chains and market dynamics. Key highlights of the report include: Technological Advancements: The latest advancements in semiconductor machinery, highlighting innovations that are boosting production efficiency and driving next-generation semiconductor development. Market Drivers: An analysis of the rise of AI, IoT, and 5G technologies as key market drivers, significantly increasing the demand for advanced semiconductor machinery. Regional Market Dynamics: Insights into regional dynamics, focusing on the contributions and dominance of key players in North America, Asia-Pacific, and Europe. With semiconductor machinery manufacturing at the forefront of technological innovation, the report serves as an essential resource for industry professionals, investors, and companies looking to stay ahead in a highly competitive market. The report is now available on Benchmark International's website and is part of the firm’s ongoing efforts to provide comprehensive market intelligence to its clients. For more information and to access the full 2024 Global Semiconductor Machinery Manufacturing Industry Report, please visit https://www.benchmarkintl.com/insights/global-semiconductor-machinery-manufacturing-industry-report/ ABOUT BENCHMARK INTERNATIONAL: Benchmark International is a global M&A firm that provides business owners with creative, value-maximizing solutions for growing and exiting their businesses. Benchmark International has handled over $11 billion in transaction value across various industries from offices across the world. With decades of M&A experience, Benchmark International’s transaction teams have assisted business owners with achieving their objectives and ensuring the continued growth of their businesses. The firm has also been named the Investment Banking Firm of the Year by The M&A Advisor and the Global M&A Network as well as the #1 Sell-side Exclusive Privately-held M&A Advisor in the World by Pitchbook and Refinitiv's Global League Tables. Contact Details Brittney Zoeller +1 813-898-2350 zoeller@benchmarkintl.com Company Website https://www.benchmarkintl.com/

August 29, 2024 09:00 AM Eastern Daylight Time

Image

Nuvectis Pharma Rises in Pre-Market Following FDA Orphan Drug Designation for NXP800, Fueling Optimism Ahead of Key Clinical Data

Global Markets News

Nuvectis Pharma (NASDAQ: NVCT) has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting Orphan Drug Designation for its lead candidate, NXP800. This designation, specifically for the treatment of ARID1a-deficient ovarian, fallopian tube, and primary peritoneal cancers, marks a critical step forward in Nuvectis’s mission to address unmet needs in oncology. Orphan Drug Designation: A Strategic Advantage The FDA’s Orphan Drug Designation is awarded to drugs that show promise in treating rare diseases affecting fewer than 200,000 people in the U.S. For Nuvectis, this designation not only validates the potential of NXP800 but also provides several strategic benefits. These include tax credits for clinical trial costs, exemption from certain FDA fees, and potentially seven years of market exclusivity upon approval. NXP800 targets ARID1a-deficient cancers, a subset of ovarian cancers that present significant treatment challenges. The Orphan Drug Designation underscores the importance of this candidate in potentially offering a new, more effective treatment option for patients with this specific genetic mutation. Background and Market Impact This latest achievement builds on Nuvectis Pharma’s earlier successes. Earlier this year, the FDA granted Fast Track Designation to NXP800 for its development in platinum-resistant, ARID1a-mutated ovarian cancer. The Fast Track status, combined with the Orphan Drug Designation, highlights the urgent need for innovative treatments in this space and positions NXP800 as a potential game-changer in oncology. Financial analysts have taken note of Nuvectis’s progress. H.C. Wainwright recently reiterated its buy rating for Nuvectis, setting a price target of $21. This optimistic outlook reflects the market’s confidence in the company’s strategic direction, particularly as it prepares to release key clinical data later this year. Anticipation for Upcoming Results The next few months are expected to be pivotal for Nuvectis Pharma. The company is poised to share updates from its ongoing Phase 1b clinical trial of NXP800, which targets patients with platinum-resistant, ARID1a-mutated ovarian cancer. This trial is being closely watched, as positive results could significantly advance the development of NXP800, bringing it closer to pivotal trials and eventual regulatory approval. Additionally, Nuvectis is also conducting a Phase 1a dose escalation study for NXP900, its second key candidate, which targets YES1/SRC-driven tumors. Updates from this study are expected to provide further insights into the safety and potential efficacy of NXP900. ### Nuvvectis' Full announcment, titled " Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers" was published on August 29th, 2024. ### This article is for informational purposes only and is not intended to serve as financial, investment or any form of professional advice, recommendation or endorsement. Please review the full documentation detailing financial compensation disclosures and disclaimers the article is subject to. https://justpaste.it/fcm9n/pdf. Global Markets News Network is a commercial digital brand compensated to provide coverage of innovative companies and industries and it is thus subject to conflicts of interest. Contact Details Global Markets News News Coverage ronald@futuremarketsresearch.com

August 29, 2024 08:20 AM Eastern Daylight Time

News Release

Railtown AI Technologies (CSE: RAIL) (OTCQB: RLAIF): Leveraging AI to Revolutionize Software Development Efficiency

Railtown AI

The global artificial intelligence (AI) market was estimated at $196.63 billion in 2023 and is expected to grow at a staggering compound annual growth rate (CAGR) of 36.6% from 2024 to 2030, according to Grand View Research. Once seen as the stuff of science fiction, AI has steadily integrated into our daily lives, evolving from a buzzword to a household presence. More importantly, AI is now a cornerstone of modern business, driving efficiencies, cutting costs, and enabling companies to compete in an increasingly digital world. Businesses are harnessing AI in various ways: enhancing cybersecurity, managing fraud, crafting content, and improving customer relationships. A Forbes survey reveals that over half of business owners use AI for cybersecurity, nearly half use it for internal communications, and 64% believe it will strengthen customer relationships. Additionally, 97% of business owners see AI tools like ChatGPT as beneficial to their operations, with many planning to use AI for website content and multilingual communication. Investing in AI stocks has surged as companies across sectors leverage advanced AI technologies to boost productivity and enhance decision-making. This shift is expected to drive revenue and earnings growth in the coming years. With that in mind, it could be the right time to start looking into AI stocks. Now, let’s look at a rising company in this competitive sector. Railtown AI Technologies (CSE: RAIL) (OTCQB: RLAIF) is emerging as a promising player in the AI sector, offering innovative solutions that streamline software development. As a Microsoft Partner, Railtown AI has developed a cloud-based Application General Intelligence (AGI) platform designed to support software developers and Agile teams. The company’s primary focus is to save time on repetitive tasks, improve productivity, reduce costs, and accelerate developer velocity. This platform is readily accessible via Microsoft's Azure Marketplace, making it easily available to a broad range of businesses. What Railtown AI Technologies Does Railtown AI ’s proprietary platform is entirely owned and developed in-house, ensuring that the company has complete control over its technology. The platform is particularly notable for its dual deployment options, catering to organizations with different needs by offering both cloud-based and on-premise solutions. This flexibility, combined with the platform’s ability to process data quickly and learn over time, allows businesses to make real-time decisions and continuously improve their software development processes. The platform’s AI-driven tools target key areas in software development, offering significant benefits. The Root Cause Analyzer detects and alerts developers to errors early, allowing them to resolve issues before they affect users, thereby saving valuable time and reducing costs. The Conductor AI Assistant provides developers with quick, accurate information to solve problems faster, continuously learning from developer feedback to improve its capabilities. The Velocity Dashboard tracks the performance of development teams, helping management make informed decisions on resource allocation and performance management. Additionally, tools like the Release Notes Automator and Ticket Generator automate traditionally manual tasks, further boosting productivity and enabling teams to focus on more strategic work. Why It Matters In a world where software development is increasingly complex and fast-paced, the ability to streamline processes and reduce manual work is critical. Railtown AI’s platform addresses this need by offering tools that not only enhance developer productivity but also ensure higher-quality software. This is particularly important as the industry moves towards Agile practices, which prioritize quick iterations and continuous improvement. By enabling faster and more accurate development cycles, Railtown AI helps organizations stay competitive in a rapidly evolving market. Moreover, Railtown AI's focus on compliance with industry standards such as SOC 2, GDPR, and ISO 27001 is a significant advantage. These compliance achievements build customer trust by ensuring that the platform handles data responsibly and securely. In industries like finance and healthcare, where data protection is paramount, this compliance is not just a nice-to-have but a necessity. As Railtown AI continues to meet these standards, it positions itself as a trustworthy partner for businesses looking to integrate AI into their software processes. The Potential of Railtown AI Technologies Railtown AI has achieved several milestones that indicate its potential for growth. The company recently announced its debt-free status, strengthened its capital base through private placements, and made significant progress in meeting compliance requirements. These achievements, combined with strategic partnerships with leading institutions like the Mila Quebec AI Institute and Amii Alberta Machine Learning Institute, set the stage for future growth. These partnerships are particularly noteworthy as they provide Railtown AI with access to cutting-edge research and development support. For instance, Mila covers 90% of project costs for its research phase with Railtown, while Amii covers 50% of project costs. This financial support, coupled with expertise from PhD candidates and machine learning engineers, enhances Railtown AI ’s ability to innovate and improve its platform. Looking ahead, Railtown AI is poised to capitalize on its compliance achievements by investing in customer acquisition, marketing, and direct sales. The company’s plans to update its patents and explore certification as a vendor for major brands further bolster its growth prospects. As Railtown AI Technologies continues to enhance its platform and expand its market presence, its strategic innovations and strong growth potential make it a compelling stock to watch in the rapidly evolving AI sector. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Awareness Consulting to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700 mark@razorpitch.com Company Website https://razorpitch.com

August 29, 2024 06:00 AM Eastern Daylight Time

Munich-based deep tech Start-up Xplain Data named IDC Innovator for Industrial AI Applications and Solutions, 2024

Xplain Data GmbH

Munich, August 28, 2024 (ThriveNewsWire ) – Xplain Data GmbH, a pioneer in Causal AI, has been named IDC Innovator in the IDC Innovators: “Industrial AI Applications and Solutions, 2024” Report. (Doc # EUR252446124, August 2024) The IDC Innovator report highlights emerging vendors offer a new technology, a groundbreaking solution to an existing issue, and/or an innovative business model. Xplain Data GmbH is one of three vendors included in the report. Xplain Data's groundbreaking Causal AI solutions empower businesses to uncover critical, hidden causal relationships within their real-world production data. AI-powered Root Cause Analysis for Production Optimization By autonomously pinpointing the root causes of critical manufacturing anomalies and failures in real-time to quality managers, Xplain Data helps businesses optimize production processes. Actionable insights into causal relationships in production data enable manufacturers to proactively prevent issues before they occur, resulting in reduced downtime, less scrap, and increased throughput. Xplain Data’s patented ObjectAnalytics data storage system is the foundation for integrating data from all production stages and diverse sources. By structuring data around business objects like the “produced part”, it creates a unified, object-centric view. This holistic approach enables Xplain Data’s Causal AI algorithms to analyze complete output data, providing a comprehensive 360° view for making evidence-based decisions and developing impactful interventions. Dr. Michael Haft, CEO and Founder of Xplain Data, commented, “Being recognized as an IDC Innovator is a tremendous honor. Our patented technologies and groundbreaking Causal AI methodologies continue to drive industry transformation, enabling organizations to make evidence-based decisions with unprecedented confidence to optimize production processes. We view this recognition as a validation of our decade-long commitment to revolutionizing the way companies extract value from their data.” Full Report (Paywall): https://www.idc.com/getdoc.jsp?containerId=EUR252446124 About Xplain Data Xplain Data is a Munich-based deep-tech pioneer revolutionizing how businesses extract value from their data. Our patented Causal AI technology unveils hidden cause-and-effect relationships buried beneath layers of correlation, empowering organizations to make evidence-based decisions with unprecedented confidence. By identifying the root causes of problems or the drivers of success, clients across engineering, manufacturing, and healthcare optimize operations, reduce errors, and achieve their business goals. Xplain Data GmbH, founded in 2015, is still 100% owned by the founding team of four experienced data and AI enthusiasts. About IDC Innovators An IDC Innovators report presents a set of vendors – under $100M in annual revenue at the time of selection – chosen by an IDC analyst within a specific market that offers a new technology, a groundbreaking solution to an existing issue, and/or an innovative business model. It is not an exhaustive evaluation or a comparative ranking of all companies, but rather a document highlighting innovative companies in a specific market segment. IDC INNOVATOR and IDC INNOVATORS are trademarks of International Data Group, Inc. Contact Details Xplain Data Monika Roy Monika.Roy@xplain-data.com

August 28, 2024 12:12 PM Eastern Daylight Time

How You Could Profit From The 2024 US Election With VantagePoint’s AI Software

Benzinga

By James Blacker, Benzinga U.S. stocks seem to be recovering following a recession scare in July that saw the S&P500 falling nearly 10% from its all-time high. The index has now risen almost 10% since the August 5 low, with the rebound partly driven by a series of economic reports this month on retail sales, inflation and producer prices, which have raised expectations that the Federal Reserve will cut interest rates later this year. However, with Vice President Kamala Harris set to square off against former president Donald Trump on November 5, analysts are warning that there could be more market turbulence yet to come, particularly with Harris leading in many polls after replacing President Joe Biden as the Democratic nominee. Election years typically bring volatility to global markets, and as election day looms, traders can expect to see intensifying fluctuations and shifts in investor sentiment. In fact, in a survey published by JPMorgan earlier this year, 20% of traders said they expected the election to be the biggest driver of stock movements this year. Why Elections Affect The Stock Market Presidential elections have wide-reaching ramifications for businesses and the economy, as they typically result in policy changes that can have a significant impact on various sectors. For instance, policy changes in healthcare can impact pharmaceutical stocks, while shifts in energy policy could affect oil and gas or renewables companies. Regulatory changes, fiscal policies, trade agreements and spending priorities can all be affected by election outcomes, creating both risks and opportunities for investors. Additionally, with so much uncertainty surrounding the future of the economy, global markets tend to be highly volatile as investors react to the latest polling data and presidential debates. This can potentially mean big price swings, making it crucial for traders to stay up to date with all the latest developments. During election periods, many traders tend to flock to commodities, indices and FX. In 2016, for example, after the UK’s referendum to leave the EU, the Germany Dax 40 index was the most traded instrument and the EUR-USD pair was the second most in demand instrument. How To Trade During Elections A golden rule for traders and investors is never to allow your own political views to inform your investing decisions. According to surveys conducted by the Pew Research Center, Democrat-aligned voters view the country’s economic condition as good under a Democratic president, while Republican-aligned voters rate the economy positively under a Republican president. This is despite the fact that average annual returns on the S&P500 were similar under both Obama and Trump, at 16.3% and 16%, respectively. Trading during an election year requires taking a strategic approach. With the right tools and strategies, investors can turn the heightened volatility into an opportunity to profit. Having access to reliable, real-time data and predictive analytics is crucial to making informed decisions. VantagePoint, a leader in A.I.-driven market forecasting software, can provide the insights needed to navigate the year of elections. Preparing For The 2024 Election With VantagePoint’s A.I. Software VantagePoint uses trained neural networks to provide traders with what it says are highly accurate, predictive forecasts of primary markets. These forecasts are based on intermarket analysis, meaning that the software compiles and analyzes data about the interconnectedness of global markets to detect hidden patterns that are undetectable by humans. Whereas traditional lagging indicators such as moving averages are simply a reaction to past price action, VantagePoint says its leading indicators can generate market predictions with up to 87.4% accuracy, and give you a head start on other traders. VantagePoint can also help you find exactly what to trade. There are thousands of securities to choose from, and it’s often the biggest decision you make as a trader. VantagePoint’s software helps you make asset selections, pinpointing the best stocks and options to trade. It even works with forex, crypto, futures and commodities. With VantagePoint's Intelliscan, you can quickly identify assets with a high potential to take off. The company says that this advanced scanning tool evaluates thousands of assets, highlighting the best stock and options opportunities. With clear, actionable insights, you can confidently target what to trade, armed with knowledge that helps you identify which stocks are likely to rise and which ones to avoid. This means you can potentially make smarter trades and maximize your time while minimizing effort. Traders and investors looking to get an edge in the markets during the election year could consider incorporating VantagePoint’s software into their trading strategies. With its A.I.-driven forecasts, traders can get a better understanding of future market movements and position themselves for success. VantagePoint is currently offering a free guide, called Electionomics 2024, which provides trading strategies that can maximize your profit during the election season using predictive artificial intelligence. For more information on VantagePoint, visit www.vantagepointsoftware.com. Featured photo by Tumisu from Pixabay. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains advertising content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 28, 2024 09:15 AM Eastern Daylight Time

Image

Enchampion Unveils Advanced Sodium-Ion Battery Solution for Satellite Applications

Rev Up Marketers

Enchampion, a technology company that specializes in high-power battery solutions, has announced the launch of its groundbreaking sodium-ion battery solution designed specifically for satellite applications. The newly launched battery pack is hermetically sealed, ensuring that it remains unaffected by the harsh conditions of space. It features an integrated Circuit Interrupt Device (CID) and burst disk, providing an additional layer of safety by preventing overpressure situations. The built-in heater ensures optimal performance even in low-temperature environments, while the cell balancing module maximizes the efficiency and lifespan of the battery. This recent development and innovation by Enchampion address the growing demand for efficient, sustainable, and cost-effective power solutions in space exploration, marking a significant leap forward in energy storage technology. Enchampion's sodium-ion battery solution has undergone a rigorous testing process to ensure its performance in space. The testing regimen included vibration tests, thermal vacuum tests, radiation tests, and cycle life tests. These tests are critical in simulating the conditions that the battery will face in space and ensuring that it can withstand these challenges. Moreover, Enchampion's sodium-ion batteries offer several special advantages when compared to other battery technologies. Sodium-ion batteries are less prone to thermal runaway, a condition that can lead to overheating and potential failure in lithium-ion batteries. Enchampion's sodium-ion battery has completed 50,000 cycles at a 30% Depth of Discharge (DOD) during rigorous testing. This makes sodium-ion batteries a safer alternative for space applications. Additionally, Enchampion’s sodium-ion battery's cost-effectiveness and abundance of sodium resources make them a sustainable option. These batteries are designed to deliver high performance in extreme conditions. Enchampion offers a range of high-performance battery solutions for space and aviation applications. These include lithium-sulfur batteries, solid-state batteries, and advanced lithium-ion batteries, all designed to meet the specific needs of various industries. Enchampion also provides cost-effective space solar panels and Photovoltaic Array (PVA) solutions, alongside a comprehensive range of products for aviation applications. These include solutions for commercial aircraft, helicopters, electric Vertical Take-Off and Landing (eVTOL) vehicles, and High-Altitude Pseudo-Satellites (HAPS). For more information about Enchampion and its offerings, please visit their website. About Enchampion: Founded in 2022, Enchampion specializes in high-power battery solutions, particularly for aviation applications. The company offers advanced lithium-ion and sodium-ion batteries designed for sustainability, high power, and safety, with features like long lifespans and wide temperature tolerance. Its products are aimed at the market needs of high power and energy, like aviation, racing cars, sea transportation, or other special industrial occasions. It also proactively collaborates with upstream research partners to explore the scientific boundary capabilities. Contact Details Enchampion Technology Co. Ltd Mike ZHAO enchampion@outlook.com Company Website https://www.enchampion.com/

August 28, 2024 07:26 AM Eastern Daylight Time

Image

PathAI's AISight Dx Image Management System is CE Marked for Primary Diagnosis

PathAI

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that its AISight Ⓡ Dx Image Management System (IMS) is In Vitro Diagnostic Regulation (IVDR) certified for use in primary diagnosis. The CE mark paves the way for the company's expansion in the European diagnostic pathology market, enhancing pathologists' interpretations and driving efficiencies and quality improvements within anatomic pathology laboratories. "The IVDR certification demonstrates PathAI’s unwavering commitment to providing safe, effective, and high-quality diagnostic solutions," said Andy Beck, MD, PhD, co-founder and CEO of PathAI. "It not only confirms the compliance of our AISight platform with the latest European regulations but also strengthens our ability to assist pathologists in delivering accurate diagnoses and improving patient outcomes across Europe." AISight Dx is a robust digital pathology platform meticulously designed with input from over 200 pathologists to streamline end-to-end digital pathology workflows. It offers a suite of features including best-in-class caseload balancing and assignment, image ingestion, image viewing, collaboration tools, and image and case management. The platform can also seamlessly integrate bi-directionally with laboratory information systems through AISight Link, further enhancing workflow efficiency. Anatomic pathology laboratories of all sizes and specialties – including health systems, university hospitals, and reference laboratories – can leverage the benefits of AISight. "We are thrilled to expand our focus to bring the AISight Dx Image Management System to European labs. We look forward to partnering with European labs to democratize access to digital pathology, enhance the pathologist experience, and ultimately improve patient outcomes," said Nick Brown, Chief Growth Officer at PathAI. PathAI will be exhibiting at the European Congress of Pathology from September 7 to 11, 2024. To learn more about AISight and see a demo, visit us at booth #L145 or email digitaldx@pathai.com. About PathAI PathAI is a leading provider of integrated AI and digital pathology solutions, dedicated to transforming diagnostic accuracy and operational efficiency in pathology labs worldwide. Through innovative technologies and strategic partnerships, PathAI aims to enhance patient outcomes and drive the future of medical diagnostics. Contact Details SVM Public Relations and Marketing Communications Maggie Naples +1 401-490-9700 pathai@svmpr.com Company Website https://www.pathai.com/

August 28, 2024 03:00 AM Eastern Daylight Time

E-commerce In The Age Of Artificial Intelligence

Benzinga

By Johnny Rice, Benzinga Dan Wagner, chairperson and CEO of Rezolve (NASDAQ: RZLV), was recently a guest on Benzinga’s All-Access. Rezolve Brain is an AI-powered platform for e-commerce businesses to optimize their online stores with enriched taxonomies, personalized recommendations and a conversational AI-powered shopping interface. Rezolve began trading on the NASDAQ this month. Watch the full interview here: Featured photo by Austin Distel on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 27, 2024 09:15 AM Eastern Daylight Time

Video Image